BD

The Worldwide Kidney Stone Retrieval Devices Industry is Expected to Reach $3.6 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022

Kidney stone retrieval devices are used in minimally invasive or non-invasive treatment options for the removal of kidney stones.

Key Points: 
  • Kidney stone retrieval devices are used in minimally invasive or non-invasive treatment options for the removal of kidney stones.
  • Considerably smaller ureter scopes, quartz fibers, and lithotripter probes have made the extraction of kidney stones from previously unreachable locations far safer than traditional surgical options.
  • For instance, the Dretler stone cone is one innovation that inhibits stone migration during the treatment.
  • The demand for kidney stone retrieval devices was uneven, with installation delays and a decline in manufacturing during the pandemic.

Global Home Medical Equipment (HME) Market and Technology Report 2022: Market Revenue for 2020 and 2021, Estimates for 2022, and CAGR Projections Through 2027

Retrieved on: 
Friday, September 23, 2022

DUBLIN, Sept. 23, 2022 /PRNewswire/ --The "Home Medical Equipment: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 23, 2022 /PRNewswire/ --The "Home Medical Equipment: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the global market for home medical equipment.
  • Among the various diseases managed or treated with HME, diabetes accounted for the largest share of the global HME market in 2021.
  • The increasing prevalence of respiratory diseases, diabetes, sleep disorders, hypertension and a rapidly expanding senior population are pushing the growth of the global home medical equipment market.

University of Maryland, Baltimore and Wexford Meeting Critical Demand for Wet Lab Space in Baltimore Region

Retrieved on: 
Thursday, September 22, 2022

BALTIMORE, Sept. 22, 2022 /PRNewswire/ -- University of Maryland, Baltimore (UMB) and Wexford Science & Technology, LLC, announced today that 4MLK, the newest development project in the University of Maryland BioPark, is slated to move forward, with groundbreaking this fall (2022) and delivering in summer 2024. The 8-story, 250,000-square-foot building, Phase I of a two-phase project representing a $320 million total capital investment, will provide critical wet laboratory space in downtown Baltimore for researchers and companies, flexible lab and office/support space for start-ups, and Class A office space, along with areas for convening and a conference center.

Key Points: 
  • "The BioPark is a highly sought-after location for companies seeking commercial wet lab space as well as connection to UMB and the vast resources we offer.
  • We are proud that 4MLK will deliver a high volume of new lab space to Baltimore, helping fill the severe shortage in our region."
  • "4MLK is the result of our strong, long-term partnership with UMB and critical focus on providing much needed world-class research space to private industry.
  • The UM BioPark offers high-quality lab and office space solutions for companies of all sizes, especially high-growth companies seeking connection with its academic partner, University of Maryland, Baltimore.

Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement

Retrieved on: 
Wednesday, September 21, 2022

Clovis Oncology, Inc. (NASDAQ: CLVS) and Isotopia Molecular Imaging Ltd. today announced the signing of a clinical supply agreement that provides Clovis Oncology with Isotopias lutetium-177 (177Lu) n.c.a.

Key Points: 
  • Clovis Oncology, Inc. (NASDAQ: CLVS) and Isotopia Molecular Imaging Ltd. today announced the signing of a clinical supply agreement that provides Clovis Oncology with Isotopias lutetium-177 (177Lu) n.c.a.
  • Clovis Oncology is committed to advancing FAP-2286s clinical development program and emerging as a leader in targeted radionuclide therapy.
  • A critical element to advance this program is ensuring long-term supply of radioisotopes, and this agreement further secures our ability to achieve that goal, said Patrick Mahaffy, President and CEO of Clovis Oncology.
  • Over the past four years, Isotopia has strengthened its supply chain to support the growing global demand and need for higher supply security, said Keren Moshkoviz, Deputy CEO and BD at Isotopia.

eToro introduces ESG scores as study reveals three in five retail investors consider ESG before buying stocks

Retrieved on: 
Wednesday, September 21, 2022

"ESG scores provide our customers access to information about companies not typically accounted for in traditional financial analysis.

Key Points: 
  • "ESG scores provide our customers access to information about companies not typically accounted for in traditional financial analysis.
  • Slightly fewer (22%) say concerns over greenwashing are a barrier, while 20% worry about the lack of standardization in ESG scores.
  • Our new partnership with eToro will enable more investors to access high-quality ESG scores for better decision-making, helping to align capital to more sustainable outcomes."
  • Calculated by ESG Book, the ESG scores combine the most up-to-date market news, NGO signals and company-reported information.

Babson Diagnostics Welcomes Four New Leaders to Management Team

Retrieved on: 
Tuesday, September 20, 2022

Babson Diagnostics, a science-first health care technology company, today announced that it continues to grow its management team with the addition of four key leaders.

Key Points: 
  • Babson Diagnostics, a science-first health care technology company, today announced that it continues to grow its management team with the addition of four key leaders.
  • He was regional sales director of health plans at Quest Diagnostics and has led market access for Agendia, Oncocyte, BillionToOne, and Pathnostics.
  • He has an extensive background in manufacturing operations management in the medical industry, including diagnostics, surgical tools, and point-of-care equipment.
  • Babson, based in Austin, Texas, was founded by individuals with deep experience in healthcare, diagnostics, engineering, and laboratory technologies.

BD Foundation Advances Health Equity, Education through Support of International Council of Nurses

Retrieved on: 
Monday, September 19, 2022

FRANKLIN LAKES, N.J., Sept. 19, 2022 /PRNewswire/ -- The BD Foundation, the philanthropic arm of global medical technology company BD (Becton, Dickinson and Company), today announced a three-year commitment to invest in the development of National Nursing Associations (NNAs) to support health equity and advance nursing education across 21 countries in Africa.

Key Points: 
  • The announcement was made at the Clinton Global Initiative 2022 and supports on-the-ground work of the International Council of Nurses (ICN) to advance nursing capacity in these countries.
  • This investment enables expanded economic opportunity, addresses health equity and achieves better health outcomes for vulnerable patient populations in low- and middle-income countries.
  • And that is why we are grateful to the BD Foundation today, for adding their substantial backing to this important initiative."
  • The International Council of Nurses (ICN) is a federation of more than 130 national nurses associations (NNAs), representing the 28 million nurses worldwide.

Global Insulin Drug and Delivery Technology Markets Report 2022: Historic Market Revenue for 2020 and 2021, Estimates for 2022, and CAGR Projections Through 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 19, 2022

The current report will provide an in-depth look at the insulin drug and delivery technologies market.

Key Points: 
  • The current report will provide an in-depth look at the insulin drug and delivery technologies market.
  • This report analyzes the market trends of insulin drug and delivery technologies with data from 2021, estimates from 2022, projections of compound annual growth rates through 2027 (forecast period 2022-2027), and regional markets of the insulin drug and delivery technologies.
  • This report will highlight the current and future market potential of insulin drug and delivery technologies along with a detailed analysis of the competitive environment.
  • The global market for insulin drug and delivery technologies is segmented by device type, insulin type and region.

Home Medical Equipment (HME) Technologies and Global Markets Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 19, 2022

The "Home Medical Equipment: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Home Medical Equipment: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the global market for home medical equipment.
  • The increasing prevalence of respiratory diseases, diabetes, sleep disorders, hypertension and a rapidly expanding senior population are pushing the growth of the global home medical equipment market.
  • Also, pandemics like the 2019 novel coronavirus (COVID-19) drive the global demand for home medical equipment.

LivaNova Board Appoints Brooke Story as a New Director

Retrieved on: 
Thursday, September 15, 2022

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the LivaNova Board of Directors appointed Brooke Story to the Board, effective September 15, 2022.

Key Points: 
  • LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the LivaNova Board of Directors appointed Brooke Story to the Board, effective September 15, 2022.
  • In addition, Story will be a member of the Nominating and Corporate Governance Committee of the Board.
  • Story joins the LivaNova Board with more than 20 years of experience in the global medical technology industry.
  • Over the course of her career, Brooke has excelled in helping large medical device corporations inspire their teams, mentor and develop talent, and deliver economic value, said William Kozy, Chair of the LivaNova Board.